These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6747349

  • 1. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis.
    Lodemann E, Kornhuber B, Gerein V, von Il'berg C.
    J Interferon Res; 1984; 4(2):283-90. PubMed ID: 6747349
    [Abstract] [Full Text] [Related]

  • 2. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E, Nitsche EM, Lang MH, Gerein V, Altmeyer P, Holzmann H, Kornhuber B.
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [Abstract] [Full Text] [Related]

  • 3. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
    Gerein V, Lodemann E, Bell G, von Ilberg C, Kornhuber B.
    Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
    Grups JW, Komprecht B.
    J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
    [Abstract] [Full Text] [Related]

  • 5. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M, Akashi K, Nakamura Y, Matsumoto K, Yamaguchi H, Takamatsu S, Shimizu T.
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [Abstract] [Full Text] [Related]

  • 6. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
    Vacher S, Peytral C, Narcy P.
    Presse Med; 1985 Jun 15; 14(24):1317-8. PubMed ID: 3161020
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined CO2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis.
    Mattot M, Ninane J, Hamoir M, Moulin D, Mustin V, Vermylen C, Cornu G.
    Acta Clin Belg; 1990 Jun 15; 45(3):158-63. PubMed ID: 2166413
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH, Storer B, Witt PL, Nelson B, Brown RR, Horisberger M, Grossberg S, Borden EC.
    Cancer Res; 1990 Aug 01; 50(15):4588-94. PubMed ID: 2114942
    [Abstract] [Full Text] [Related]

  • 12. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A, Merlin G, Bregman V, Hahn T, Levin S, Revel M, Wallach D.
    Clin Exp Immunol; 1984 Aug 01; 57(2):265-70. PubMed ID: 6467673
    [Abstract] [Full Text] [Related]

  • 13. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ, Short EC, Burge LJ, Winter DA, Fulton RW.
    Am J Vet Res; 1990 Jun 01; 51(6):886-92. PubMed ID: 1695068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High level activity of 2', 5'-oligoadenylate synthetase in dog serum.
    Iwata A, Yamamoto A, Fujino M, Sato I, Hosokawa-Kanai T, Tuchiya K, Ishihama A, Sokawa Y.
    J Vet Med Sci; 2004 Jun 01; 66(6):721-4. PubMed ID: 15240951
    [Abstract] [Full Text] [Related]

  • 16. Lightmicroscopical features of interferon-alpha-treated laryngeal papillomatosis in adults.
    Bomholt A, Oestergaard B, Horn T.
    Acta Otolaryngol; 1986 Jun 01; 102(1-2):131-5. PubMed ID: 3739686
    [Abstract] [Full Text] [Related]

  • 17. Changes of serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C.
    Solinas A, Cossu P, Poddighe P, Tocco A, Deplano A, Garrucciu G, Diana MS.
    Liver; 1993 Oct 01; 13(5):253-8. PubMed ID: 8259037
    [Abstract] [Full Text] [Related]

  • 18. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F, Estrov Z, Kurzrock R, Breitmeyer JB, Maschek BJ, Talpaz M.
    Clin Cancer Res; 1999 Dec 01; 5(12):3990-8. PubMed ID: 10632330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
    Merritt JA, Borden EC, Ball LA.
    J Interferon Res; 1985 Dec 01; 5(1):191-8. PubMed ID: 3989336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.